Formulated Solutions

The path from concept to commercialization requires more than manufacturing. It requires experience. Medical device programs demand precision, regulatory expertise, and consistent execution. At Formulated Solutions, we partner with innovators to help bring FDA-regulated medical devices and combination products to market with confidence. From formulation and device assembly to packaging and commercial manufacturing, our integrated team provides the technical expertise and quality systems needed to support your product throughout its lifecycle. Our expertise includes: • Medical Device Assembly & Kitting • Topical Semisolids • Anesthetic & Vapocoolant Sprays • Cryosurgery & Cryoablation Products • Nasal Irrigation Systems • Wound Care Solutions Backed by 25+ years of FDA Class I & II manufacturing experience, 5 ISO certifications, and a robust quality management system, we help customers reduce risk, accelerate commercialization, and deliver products that meet the highest standards of quality. Whether you're launching an innovative device, transferring production, or scaling manufacturing, Formulated Solutions is ready to help you move forward. 📧 [email protected] 🌐 https://lnkd.in/eD7mP5Y #MedicalDevice #MedicalDeviceManufacturing #CDMO #MedicalInnovation #ContractManufacturing #CombinationProducts #FDA #Commercialization #QualitySystems #HealthcareManufacturing #FormulatedSolutions

The countdown to CPHI Milan 2026 has officially begun, and Formulated Solutions is looking forward to connecting with customers, partners, and innovators from around the world! 🌍 As a leading CDMO, we're excited to discuss how we help pharmaceutical and consumer healthcare brands move products from development through commercial manufacturing with the quality, technical expertise, and manufacturing capabilities they need to succeed. If you'll be attending CPHI Milan, now is the perfect time to schedule a meeting with our team and start the conversation before the show begins. Meet with: Victor Swint Marcel Baumann Derek Bush M. Scott Carpenter, MBA Jonathan Puentes, MBA Rehan Khanzada Stephen Panaro, Ph.D. Kyle Gordon Visit us at Booth 12P50 📅 October 6-8, 2026 📍 Fiera Milano | Milan, Italy Schedule your meeting today: 📧 [email protected] We look forward to seeing you in Milan and discussing how Formulated Solutions can support your next pharmaceutical or consumer healthcare program. https://lnkd.in/e39FuhE #CPHIMilan #CPHI #CDMO #PharmaceuticalManufacturing #ContractManufacturing #DrugDevelopment #DrugDelivery #Aerosol #BagOnValve #Topicals #OralLiquids #NasalSpray #FormulatedSolutions

Rx-to-OTC switches are accelerating in nasal. US fill capacity isn't. The next few years will reshape established nasal franchises. Switch candidates are advancing, generics are entering categories that have been quiet for a decade, and brand teams are being asked to launch faster, cleaner, and with a credible sustainability story attached to the device. Most brand owners we talk to don't want another vendor to manage. They want a partner who can take a program from formulation through commercial fill, coordinate device strategy alongside the molecule, and stand up to FDA inspection cleanly. US domestic capacity for multi-dose nasal, particularly non-sterile suspensions is genuinely constrained, and supply chain resilience has moved from a procurement preference to a board-level concern. That's the work we do. Formulated Solutions runs two US GMP campuses across roughly 800,000 square feet, supporting Rx-to-OTC switches, generic launches, Rx development, commercial fill finish, branded OTC programs, and lifecycle extensions end-to-end, formulation, analytical, scale-up, commercial fill, packaging. If you're stress-testing your nasal supply strategy or pressure-testing a switch program, let's talk. We'll be at CPHI Philadelphia, Booth #620, June 2–4. FormulatedSolutions.com #CDMO #NasalSpray #ConsumerHealth #RxtoOTCSwitch

We're heading to CPHI 2025! With our agile approach and passion for innovation, we can help you solve problems you haven’t yet identified across Rx therapeutics, OTC and medical devices. Book your meeting now or visit us at booth 6.1D78 — let’s grow together

Join Formulated Solutions September 18–19 in New Brunswick, NJ—where Matt Unger, M. Scott Carpenter and Stephen Panaro, Ph.D. will be ready to discuss: - Early‑stage development for topical, nasal and liquid products - End‑to‑end support from clinical supply through commercial manufacturing - US‑based production of finished goods Want to talk timing, quality or regulatory strategy? Let’s connect—email [email protected] to reserve your slot.

Bringing your Rx therapy to market shouldn’t mean fitting into a one-size-fits-all solution. At Formulated Solutions, we support you from early development to full-scale production—customizing every step to fit your needs. Specializing in advanced topicals, nasal sprays and oral dose liquids, we offer the expertise to take your therapy from concept to reality. We offer the expertise and flexibility to create purpose-built GMP manufacturing environments, ensuring a seamless transition from R&D to commercial success. Let’s formulate something Rx-traordinary together.